These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11859242)
1. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma. Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variants in osteosarcoma. Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms. Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543 [TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor). Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
8. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance]. Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of CD44v6 and MMP2 predicts lung metastasis and unfavorable prognosis in osteosarcoma. Liang S; Li L; Guo Z; Sun H; Yang Y Future Oncol; 2024; 20(25):1799-1806. PubMed ID: 39011948 [TBL] [Abstract][Full Text] [Related]
11. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. Endo K; Terada T J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070 [TBL] [Abstract][Full Text] [Related]
12. CD44 splice variants as prognostic markers in colorectal cancer. Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913 [TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Ashida K; Terada T; Kitamura Y; Kaibara N Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436 [TBL] [Abstract][Full Text] [Related]
14. CD44 loss in gastric stromal tumors as a prognostic marker. Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma. Deng Z; Niu G; Cai L; Wei R; Zhao X Biomed Res Int; 2013; 2013():496193. PubMed ID: 23971040 [TBL] [Abstract][Full Text] [Related]
16. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777 [TBL] [Abstract][Full Text] [Related]
18. [Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma]. Peng TS; Qiu JS; Wu HX; Liang HZ; Luo CQ Ai Zheng; 2002 Jul; 21(7):745-50. PubMed ID: 12479099 [TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Tran TA; Kallakury BV; Sheehan CE; Ross JS Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of CD44 isoform expression in endometrial cancer. Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]